ChemNet > CAS > 89105-94-2 L-Valine,L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-
89105-94-2 L-Valine,L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-
| product Name |
L-Valine,L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl- |
| Synonyms |
L-Valine,N-[N-[N-[N-[N2-[N2-[N-[N-[N-[N-(N-L-histidyl-L-histidyl)-L-leucyl]glycyl]glycyl]-L-alanyl]-L-lysyl]-L-glutaminyl]-L-alanyl]glycyl]-L-a-aspartyl]-; Fibrinogen g-chain fragment analog; Fibrinogen-binding inhibitor peptide; Human fibrinogen g-400-411 peptide; 10: PN: JP2002320666SEQID: 10 claimed protein; 125: PN: WO2008058016 SEQID: 126 claimed protein; 126: PN: US20030225251 SEQID: 134 claimed sequence; 15: PN: US20070065361SEQID: 16 unclaimed sequence; 16: PN: US20040191249 SEQID: 16 claimed sequence; 1: PN: US7049140 SEQID: 1 claimed protein; 1: PN: WO2004069862 SEQID: 1unclaimed sequence; 24: PN: WO2004069875 PAGE: 69 claimed sequence; 29: PN:US7521540 SEQID: 29 unclaimed sequence; 29: PN: WO0155210 SEQID: 29 unclaimedsequence; 32: PN: US6790606 SEQID: 29 unclaimed sequence; 3: PN: WO02072619PAGE: 8 unclaimed sequence; 4: PN: WO2004058305 PAGE: 39 claimed protein; 4:PN: WO2005035002 PAGE: 8 unclaimed sequence; 6: PN: WO0066182 SEQID: 1 claimedprotein; 7: PN: US20060046271 SEQID: 19 unclaimed sequence; His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val |
| Molecular Formula |
C50H80N18O16 |
| Molecular Weight |
1189.28 |
| CAS Registry Number |
89105-94-2 |
| Molecular Structure |
|
| Density |
1.342g/cm3 |
| Boiling point |
1809.886 °C at 760 mmHg |
| Flash point |
1048.381 °C |
| Hazard Symbols |
|
| Risk Codes |
|
| Safety Description |
|
|
